NP
Ninepoint Partners’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $806K | Sell |
7,502
-576
| -7% | -$61.9K | 0.13% | 68 |
|
|
2025
Q1 | $815K | Sell |
8,078
-726
| -8% | -$73.2K | 0.14% | 69 |
|
|
2024
Q4 | $786K | Hold |
8,804
| – | – | 0.11% | 74 |
|
|
2024
Q3 | $738K | Buy |
+8,804
| New | +$738K | 0.08% | 66 |
|
|
2020
Q1 | – | Sell |
-34,515
| Closed | -$1.56M | – | 54 |
|
|
2019
Q4 | $1.56M | Sell |
34,515
-16,382
| -32% | -$741K | 0.51% | 18 |
|
|
2019
Q3 | $2.07M | Sell |
50,897
-7,052
| -12% | -$287K | 0.79% | 16 |
|
|
2019
Q2 | $2.49M | Buy |
57,949
+39,546
| +215% | +$1.7M | 0.46% | 22 |
|
|
2019
Q1 | $706K | Sell |
18,403
-6,097
| -25% | -$234K | 0.13% | 40 |
|
|
2018
Q4 | $866K | Sell |
24,500
-100,000
| -80% | -$3.53M | 0.24% | 28 |
|
|
2018
Q3 | $4.79M | Buy |
+124,500
| New | +$4.79M | 0.83% | 24 |
|